Mobile App

Google Play Apple Store
Neurofibromatosis Type 1-Related Plexiform Neurofibromas: Improving Diagnosis and Monitoring While Integrating Ongoing Updates in the Treatment Continuum
AMA/ABS/ANCC Activity- Podcast Lecture Library
Patients with plexiform neurofibromas (PN) associated with neurofibromatosis type 1 (NF1) experience considerable morbidity, a poor quality of life, and increased mortality. Research efforts have led to earlier diagnosis, new monitoring approaches, emerging treatment options, and considerations for surgical intervention. To this end, it is critical that pediatric oncologists as well as other members of the multidisciplinary team neurologists caring for patients with NF1-PN are up to date on recent advances. In this podcast lecture library, Dr. Armstrong uses a case-based discussion to address the heterogeneity and complexity of this condition as well as considerations for the use of emerging therapies when making individualized management decisions among diverse patients.
Review the activity and claim AMA, ABS, or ANCC credit/contact hour after completion of a brief pretest and posttest/evaluation.




 
Amy Armstrong, MD Amy Armstrong, MD
Assistant Professor of Pediatrics
Division of Hematology/Oncology
Neurofibromatosis (NF) Center
Washington University School of Medicine
St. Louis, Missouri

20
Supported by an independent educational grant from
Alexion, AstraZeneca Rare Disease

Launch Date: October 31, 2024
Release Date: October 31, 2024
Expiration Date: September 30, 2025

Mini Module
7825
LectureLibrary_NF1-PN __Podcast_2024(1730x162).png
True
 
Hematology-Oncology

CookieConsent

Change Settings